¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Methylergonobin Maleate Injection Huons"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intra-arterial injection
    µ¿¸Æ³»ÁÖ»ç
  • intracameral injection
    ¾Õ¹æ³»ÁÖ»ç, Àü¹æ³»ÁÖ»ç
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç
  • intracutaneous injection
    ÇǺγ»ÁÖ»ç, Çdz»ÁÖ»ç
  • intracytoplasmic sperm injection
    ¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ
  • intradermal injection
    ÇǺγ»ÁÖ»ç, Çdz»ÁÖ»ç
  • intramuscular injection
    ±ÙÀ°³»ÁÖ»ç, ±ÙÀ°ÁÖ»ç
  • intraperitoneal injection
    º¹°­³»ÁÖ»ç, ¹è¸·¾ÈÁÖ»ç
  • intrapleural injection
    °¡½¿¸·¾ÈÁÖ»ç, Èä°­³»ÁÖ»ç
  • jet injection
    ºÐ»çÁÖ»ç
  • preparatory injection
    ÁغñÁÖ»ç
  • provocative injection
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • paravertebral injection
    ôÃß¿·ÁÖ»ç
  • percutaneous ethanol injection
    ÇǺΰæÀ¯¿¡Åº¿ÃÁÖ»ç, °æÇÇ¿¡Åº¿ÃÁÖ»ç
  • subcutaneous injection
    ÇǺιØÁÖ»ç, ÇÇÇÏÁÖ»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • intracameral injection
    ¾Õ¹æ³»ÁÖ»ç
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç
  • intracutaneous injection
    (¢¡intradermal injection) ÇǺγ»ÁÖ»ç
  • intracytoplasmic sperm injection
    ¼¼Æ÷Áú³»Á¤ÀÚÁÖÀÔ
  • intradermal injection
    ÇǺγ»ÁÖ»ç
  • intramuscular injection
    ±ÙÀ°³»ÁÖ»ç
  • intraperitoneal injection
    º¹¸·¾ÈÁÖ»ç, º¹°­³»ÁÖ»ç
  • intrapleural injection
    °¡½¿¸·°ø°£ÁÖ»ç, È丷°­³»ÁÖ»ç
  • intravascular injection
    Ç÷°ü³»ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³»ÁÖ»ç
  • jet injection
    ºÐ»çÁÖ»ç
  • paravertebral injection
    ôÃßÁÖÀ§ÁÖ»ç
  • preparatory injection
    ÁغñÁÖ»ç
  • provocative injection
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • sensitizing injection
    ¹Î°¨È­ÁÖ»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • fine injection
    ¹Ì¼¼¸Æ°üÁÖ»ç.
  • hypodermic injection
    ÇÇÇÏÁÖ»ç.
  • injection
    ÁÖ»ç,ÁÖÀÔ,ÃæÇ÷
  • injection aerator
    ºÐ»ç½ÄÆø±âÀåÄ¡(ËÓË×Ëà̰˻Ëö̬).
  • injection cast corrosion method
    Ç÷°üÁÖÇüÀÛÁ¦¹ý.
  • injection molding method
    »çÃ⼺Çü¹ý(ÞÒõóà÷úþÛö).
  • injection, booster
    Ãß°¡Á¢Á¾, Ãß°¡ÁÖ»ç
  • injection, eliciting
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • injection, provocative
    À¯¹ßÁ¢Á¾, À¯¹ßÁÖ»ç
  • intraarterial injection
    µ¿¸Æ³»ÁÖ»ç.
  • intraarticular injection
    °üÀý³» ÁÖ»ç(μï½Ò®ñ¼ÞÒ).
  • intracameral injection
    Àü¹æ³»ÁÖ»ç.
  • intracardiac injection
    ½ÉÀå³»ÁÖ»ç.
  • intracutaneous injection
    Çdz»ÁÖ»ç.
  • intradermal injection
    Çdz»ÁÖ»ç(¡­ñ¼ÞÒ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
GnRH Gonadotropin Releasing Hormone  [HP 1898, 2034]
  = LHRH
  = Go...
hypo. hypodermic(ally) injection; ÇÇÇÏÁÖ»ç
IDUs Injection Drug Users
IM   1) Intra-Muscular(ly) (injection); ±ÙÀ°À¸·Î, ±ÙÀ°ÁÖ»ç
  2) Infectious Mononucleus(M...
IV Intra-Venous(ly) injection; Á¤¸ÆÀ¸·Î, Á¤¸ÆÁÖ»ç
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
ICSI IVF)-intracytoplasmic sperm injection
IV Injection
IDU Injection drug use
IDU Injection drug users
125I Injection of
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • interligamentary injection syringe
    Ä¡±Ù¸·³» ÁÖÀÔ¿ë ÁÖ»ç±â
  • intra-arterial injection
    µ¿¸Æ³» ÁÖ»ç
  • intraarticular injection
    °üÀý³» ÁÖ»ç
  • intracutaneous injection
    Çdz» ÁÖ»ç
    Çdz»¿¡ ¾à¹°À» ÁÖÀÔÇÏ´Â ¹æ¹ýÀ¸·Î Áúº´ÀÇ Áø´Ü ¹× ¿¹¹æÀ» À§ÇØ Èí¼ö¸¦ ´À¸®°Ô ÇÏ°í ¾àÈ¿¸¦ °¡´ÉÇÑÇÑ Áö¼Ó½Ã۱⸦ ¹Ù¶ó´Â °æ¿ì ¹× ´Ù¸¥ ÁÖ»ç¹ýÀ¸·Î¼­´Â ºÎÀû´çÇÑ ¾àÁ¦ÀÇ °æ¿ì µî¿¡ ÇàÇØÁø´Ù. ¸¹Àº °æ¿ì ¹ÝÀÀÀÌ ´«À¸·Î º¸Àδٴ Ư¡ÀÌ ÀÖ´Ù.
  • intramuscular injection
    ±Ù³» ÁÖ»ç, ±ÙÀ°³» ÁÖ»ç, ±ÙÀ° ÁÖ»ç
    ¾àÁ¦¸¦ ±ÙÀ°¿¡ ÁÖ»çÇÏ´Â °Í. ÇÇÇÏ Áֻ翡 ºñÇØ¼­ Èí¼ö°¡ ºü¸£°í 2-5mlÀ» Àû¿ëÇÒ ¼ö ÀÖ´Ù. ÀÚ±Ø, ÅëÁõÀÌ °­ÇÑ °ÍÀ̳ª À¯¼ºÀÇ ¾àÁ¦ µî ¶Ç Èí¼ö°¡ ³ª»Û °ÍÀÌ ±ÙÀ° Áֻ翡¼­ Àû¿ëµÈ´Ù.
  • intraosseous, interseptal, intrapulpal injection
    °ñ³», Á߰ݰ£, Ä¡¼ö³» ÁÖ»ç
  • intrapulpal injection
    Ä¡¼ö ³» ÁÖ»ç
  • intravascular injection
    Ç÷°ü³» ÁÖ»ç
  • intravenous injection
    Á¤¸Æ³» ÁÖ»ç
  • mercurophylline injection
    ¸ÓÅ¥·ÎÇʸ° ÁÖ»ç¾×
  • paraperiosteal injection
    °ñ¸· ÁÖÀ§ ÁÖ»ç
  • paravertebral injection
    ôÃß ÁÖÀ§ ÁÖ»ç
  • post-injection trismus
    ÁÖ»ç ÈÄ ¾Æ°ü±ä±Þ
  • pre/post gadolinium injection
    °¡µ¹¸®´½ ÁÖÀÔÀü/ÈÄ
  • retrogasserian injection of glycerol

    retrogasserian neurotomy (°¡¼¼¸£ ½Å°æÀý Èı٠Àý´Ü¼ú

CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
pyrilamine maleate 2-[(2-dimethylaminoethyl) (p-methoxybenzyl)amino]pyridine maleate;an antihistaminic.
Synonym: mepyramine maleate.
(05 Mar 2000)
nomifensine maleate 8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline maleate;an antidepressant.
(05 Mar 2000)
dexbrompheniramine maleate <chemical> D-2-[p-Bromo-alpha-(2-dimethylaminoethyl)benzyl]pyridine maleate;the dextrorotatory isomer of brompheniramine; an antihistamine.
(05 Mar 2000)
dexchlorpheniramine maleate <chemical> D-2-[p-Chloro-alpha-(2-dimethylaminoethyl)benzyl]pyridine maleate;the dextrorotatory isomer of chlorpheniramine; an antihistamine.
(05 Mar 2000)
dimethindene maleate 2-[1-[2-(2-Dimethylaminoethyl)inden-3-yl]ethyl]pyridine maleate;an antihistamine also used as an antipruritic.
(05 Mar 2000)
dizocilpine maleate <chemical> 10,11-dihydro-5-methyl-5h-dibenzo(a,d)cyclohepten-5,10-imine maleate. A potent noncompetitive antagonist of the nmda receptor (receptors, n-methyl-d-aspartate) used mainly as a research tool. The drug has been considered for the wide variety of neurodegenerative conditions or disorders in which nmda receptors may play an important role. Its use has been primarily limited to animal and tissue experiments because of its psychotropic effects.
Pharmacological action: excitatory amino acid antagonists, neuroprotective agents.
Chemical name: 5H-Dibenzo(a,d)cyclohepten-5,10-imine, 10,11-dihydro-5-methyl-, (5S)-, (Z)-2-butenedioate (1:1)
(12 Dec 1998)
thiethylperazine maleate 2-Ethyl-mercapto-10-3-(1-methyl-4-piperazinyl)propyl phenothiazine dimaleate;an antiemetic agent used to control nausea and vomiting associated with vertigo, the administration of general anaesthetics, and with several other clinical conditions; it also has weak hypotensive, spasmolytic, antihistaminic, and hypothermic actions.
(05 Mar 2000)
timolol maleate (-)-1-(tert-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate;a beta-adrenergic blocking agent used in the treatment of hypertension and used in eyedrops in the treatment of chronic open-angle glaucoma.
(05 Mar 2000)
enalapril maleate L-Proline, 1-[N-[1-(ethoxycarbonyl)-3-phenylpropyl]-l-alanyl]-,(S)-, (Z)-2-butenedioate (1:1);a prodrug for enalaprilat, an angiotensin-converting enzyme inhibitor used as an anti-hypertensive agent.
(05 Mar 2000)
ergometrine maleate ergonovine maleate
adrenal cortex injection An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease.
(05 Mar 2000)
bolus injection <procedure> The injection of a drug (or drugs) in a high quantity (called a bolus) at once, the opposite of gradual administration (as in intravenous infusion).
(18 Nov 1997)
regular insulin injection A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma.
Synonym: regular insulin injection.
(05 Mar 2000)
Ringer's injection A sterile solution of sodium chloride, potassium chloride, and calcium chloride, containing in each 100 ml between 820 and 900 mg of sodium chloride, between 25 and 35 mg of potassium chloride, and between 30 and 37 mg of calcium chloride; used intravenously as a fluid and electrolyte replenisher.
(05 Mar 2000)
water for injection Water purified by distillation for the preparation of products for parenteral use.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á